Aspen Pharmacare Holdings Ltd (APN) - Financial and Strategic SWOT Analysis Review

  • ID: 1291946
  • SWOT Analysis
  • 53 pages
  • GlobalData
  • Aspen Holdings
1 of 5

FEATURED COMPANIES

  • AstraZeneca Plc
  • Baxter International Inc
  • Merck & Co Inc
  • Novartis AG
  • Pfizer Inc
  • MORE
Aspen Pharmacare Holdings Ltd (APN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Aspen Pharmacare Holdings Ltd (Aspen) is a specialty and generic pharmaceuticals company that provides pharmaceutical drugs for a range of acute and chronic conditions. The company also manufactures infant nutritionals and consumer healthcare products in selected territories. Its manufacturing capabilities cover a range of product-types including oral solid dose, semi-solids, liquids, steriles, biological, active pharmaceutical ingredients (APIs) and infant nutritionals. The company has presence across Sub-Saharan Africa, Latin America, South East Asia, Eastern Europe, Western Europe and the Commonwealth of Independent States. Aspen is headquartered in Durban, South Africa.

Aspen Pharmacare Holdings Ltd Key Recent Developments

Sep 14, 2017: Aspen increases revenue by 16% to R41.2 billion
Jun 13, 2017: Aspen: South African Competition Commission Announcement
May 15, 2017: Aspen: Opening of European Commission proceedings
May 15, 2017: Antitrust: Commission opens formal investigation into Aspen Pharma's pricing practices for cancer medicines
Apr 24, 2017: Aspen’s response to the reported Competition Commission investigation

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AstraZeneca Plc
  • Baxter International Inc
  • Merck & Co Inc
  • Novartis AG
  • Pfizer Inc
  • MORE
Section 1 - About the Company
  • Aspen Pharmacare Holdings Ltd - Key Facts
  • Aspen Pharmacare Holdings Ltd - Key Employees
  • Aspen Pharmacare Holdings Ltd - Key Employee Biographies
  • Aspen Pharmacare Holdings Ltd - Major Products and Services
  • Aspen Pharmacare Holdings Ltd - History
  • Aspen Pharmacare Holdings Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Aspen Pharmacare Holdings Ltd - Business Description
  • Aspen Pharmacare Holdings Ltd - Corporate Strategy
  • Aspen Pharmacare Holdings Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Aspen Pharmacare Holdings Ltd - Strengths
  • Aspen Pharmacare Holdings Ltd - Weaknesses
  • Aspen Pharmacare Holdings Ltd - Opportunities
  • Aspen Pharmacare Holdings Ltd - Threats
  • Aspen Pharmacare Holdings Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Aspen Pharmacare Holdings Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Sep 14, 2017: Aspen increases revenue by 16% to R41.2 billion
  • Jun 13, 2017: Aspen: South African Competition Commission Announcement
  • May 15, 2017: Aspen: Opening of European Commission proceedings
  • May 15, 2017: Antitrust: Commission opens formal investigation into Aspen Pharma's pricing practices for cancer medicines
  • Apr 24, 2017: Aspen’s response to the reported Competition Commission investigation
  • Mar 09, 2017: Aspen: Unaudited interim financial results for the six months ended 31 December 2016
  • Mar 01, 2017: Aspen - Trading Statement
  • Sep 14, 2016: Aspens comparable revenue increases by 12% to R35.4 billion
  • Mar 03, 2016: Aspen’s profit after tax increases by 35%
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Aspen Pharmacare Holdings Ltd, Key Facts
  • Aspen Pharmacare Holdings Ltd, Key Employees
  • Aspen Pharmacare Holdings Ltd, Key Employee Biographies
  • Aspen Pharmacare Holdings Ltd, Major Products and Services
  • Aspen Pharmacare Holdings Ltd, History
  • Aspen Pharmacare Holdings Ltd, Other Locations
  • Aspen Pharmacare Holdings Ltd, Subsidiaries
  • Aspen Pharmacare Holdings Ltd, Joint Venture
  • Aspen Pharmacare Holdings Ltd, Key Competitors
  • Aspen Pharmacare Holdings Ltd, Ratios based on current share price
  • Aspen Pharmacare Holdings Ltd, Annual Ratios
  • Aspen Pharmacare Holdings Ltd, Annual Ratios
  • Aspen Pharmacare Holdings Ltd, Annual Ratios
  • Aspen Pharmacare Holdings Ltd, Interim Ratios
  • Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Aspen Pharmacare Holdings Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Aspen Pharmacare Holdings Ltd, Performance Chart (2013 - 2017)
  • Aspen Pharmacare Holdings Ltd, Ratio Charts
  • Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Pfizer Inc
  • Novartis AG
  • Merck & Co Inc
  • Baxter International Inc
  • AstraZeneca Plc
  • Adcock Ingram Holdings Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll